GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (STU:81X) » Definitions » Gross-Profit-to-Asset %

LifeTech Scientific (STU:81X) Gross-Profit-to-Asset % : 19.41% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is LifeTech Scientific Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. LifeTech Scientific's annualized Gross Profit for the quarter that ended in Dec. 2024 was €122.3 Mil. LifeTech Scientific's average Total Assets over the quarter that ended in Dec. 2024 was €630.0 Mil. Therefore, LifeTech Scientific's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 19.41%.


LifeTech Scientific Gross-Profit-to-Asset % Historical Data

The historical data trend for LifeTech Scientific's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeTech Scientific Gross-Profit-to-Asset % Chart

LifeTech Scientific Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.54 25.53 25.12 23.19 20.66

LifeTech Scientific Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.31 25.37 22.33 21.63 19.41

Competitive Comparison of LifeTech Scientific's Gross-Profit-to-Asset %

For the Medical Devices subindustry, LifeTech Scientific's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeTech Scientific's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's Gross-Profit-to-Asset % falls into.


;
;

LifeTech Scientific Gross-Profit-to-Asset % Calculation

LifeTech Scientific's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=128.734/( (603.144+642.776)/ 2 )
=128.734/622.96
=20.66 %

LifeTech Scientific's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=122.262/( (617.169+642.776)/ 2 )
=122.262/629.9725
=19.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


LifeTech Scientific Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


LifeTech Scientific Business Description

Traded in Other Exchanges
Address
No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures also responsible for marketing of of advanced minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.

LifeTech Scientific Headlines

No Headlines